Calanus As

Biotec Asa

Biotec Pharmacon Asa

Seagarden As

Ederagen As

As Biotec-mackzymal

Jan Raa

Gunnar Rorstad

Kurt Steinar Tande

Eric De Muinck

Pål Trosvik

Gunnar Rørstad

Hilde Nat Institute Of Public Health Bakke

Liba National Institute Of Public Health Janakova

Fredrik Nat Institute Of Public Health Oftung

Johan National Institute Of Public Health Holst

Gro E Nat Institute Of Public Health Korsvold

Gunnar Roerstad

Bjorn Nat Institute Of Public Health Haneberg

Inger Lise Nat Institute Of Public Health Haugen

Borre Robertson

Aud K H Nat Instituteof Public Health Berstad

The invention comprises a defined and safe soil substitute, herein referred to as 'deconstructed soil', that supports ecological balance in anaerobic microbial ecosystems, such as that inside the human gut, by shifting energy availability to favor growth of bacteria linked with gut health, and away from the most dominant species and species that are putatively harmful. The invention enables vulnerable bacterial groups to recover from a state of apparent extinction from the ecosystem in question. As it does not contain components that are prebiotic or probiotic, the deconstructed soil represents a new product concept for preventing and treating conditions associated with dysfunctional microbial ecosystems in the gastrointestinal tract of humans and animals, as well as other anaerobic microbial ecosystems.

Deconstructed soil

This invention relates to an oil composition, preferably obtained from a copepod, and the use thereof to reduce accumulation of visceral fat and counteract impairment of heart function caused by obesity inducing Western diets. The oil composition of the present invention can thus be used to reduce abdominal obesity and improve glucose tolerance and thus to reduce the risk of obesity related diseases such as but not limited to type 2 diabetes or cardiovascular disease, or to prevent or treat such diseases.

Oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders

This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepodand the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.

Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease

The present invention relates to novel compositions comprising copepods, such as marinespecies, process for the production thereof and use of said compositions in the prevention and/or treatment of ectoparasite infestations in animals. Further the invention relates to methods for prevention and/or treatment of ectoparasite infestations in aquatic animals, particularly fish.

Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites

Novel bioactive peptide compositions and process for producing the same and the use of such compositions for enhancing the growth of warm blooded animals and fish is disclosed.

Bioactive peptides, uses thereof and process for the production of same

Growing community of inventors

Oslo, Norway

Jan Raa